GLP 1 receptor agonists and obesity-associated cancers: a disproportionality analysis in Vigibase® Jean-Louis Montastruc Correspondence 27 September 2024
Evaluation of the predictive performance of an online voriconazole dose calculator in children Abdullah AlsultanRazan AlmofadaKhalid W. Taher Research 26 September 2024
Comment on “Use of statins and risks of ovarian, uterine, and cervical diseases: a cohort study in the UK Biobank” Pei-Ying ChungKuan-Fu LiaoShih-Wei Lai Correspondence 20 September 2024
The impact of age and renal function on the pharmacokinetics and protein binding characteristics of fludarabine in paediatric and adult patients undergoing allogeneic haematopoietic stem cell transplantation conditioning Christa E. NathSebastian P. A. RosserSteven J. Keogh Research Open access 19 September 2024
Sodium-glucose cotransporter 2 inhibitors and renal cancer in the US FDA adverse event reporting system Bo XuJiecan Zhou Research 17 September 2024
Pharmacokinetics-pharmacodynamics of first-line antitubercular drugs: a comparative study in tuberculosis patients with and without concomitant diabetes mellitus Sourav MondalVandana RoySandeep Garg Research 17 September 2024
Dose reduction and discontinuation due to the combination of CDK4/6 inhibitors and endocrine drugs: a systematic review and meta-analysis Ping YangHengheng ZhangYi Zhao Review 13 September 2024
Preventive effects of first-generation antihistamine on emergence agitation or delirium: a systematic review Kazumasa KotakeSatoru MatsunumaYasuhiro Kawakami Review 12 September 2024
Efficacy and safety of ticagrelor monotherapy following a brief DAPT vs. prolonged 12-month DAPT in ACS patients post-PCI: a meta-analysis of RCTs Usama QamarFarhan NaeemYasar Sattar Review 12 September 2024
Beta-blockers and breastfeeding: a real-life prospective study Romane FreppelLouise GaboriauSophie Gautier Research 11 September 2024
Efficacy of tacrolimus versus cyclosporine after lung transplantation: an updated systematic review, meta-analysis, and trial sequential analysis of randomized controlled trials Husam Abu SuilikAli Saad Al-shammariMohamed Abuelazm Research 11 September 2024
ChatGPT does make up scientific references: should it be currently renamed CheatGPT? Gerd Mikus Correspondence Open access 10 September 2024
The cost-effectiveness analysis of semaglutide for the treatment of adult and adolescent patients with overweight and obesity: a systematic review Ali Sarabi AsiabarMohammad Ali RezaeiSamad Azari Review 10 September 2024
Approaches for posaconazole therapeutic drug monitoring and their clinical benefits Silu WangChangkun LiWeihua Dong Review 09 September 2024
Voriconazole therapeutic drug monitoring including analysis of CYP2C19 phenotype in immunocompromised pediatric patients with invasive fungal infections Matylda ResztakPaulina ZalewskaFranciszek K. Główka Research Open access 06 September 2024
Fixed parameters in the population pharmacokinetic modeling of valproic acid might not be suitable: external validation in Chinese adults with epilepsy or after neurosurgery Ruoyun WuKai LiShenghui Mei Research 29 August 2024
Reference guides for the safe use of drugs during pregnancy: a systematic review and comparative analysis Xue-Feng JiaoPanda QiuLingli Zhang Review 26 August 2024
Evaluation of pharmacokinetic target attainment and hematological toxicity of linezolid in pediatric patients Manal AbouelkheirMaram R. AldawsariAbdullah Alsultan Research 25 August 2024
Correction to: Use of antibiotics in the early COVID‑19 pandemic in Poland, the Netherlands and Spain, from erraticism to (more) logic Aleksandra OpalskaHelga GardarsdottirHubert Leufkens Correction Open access 22 August 2024 Pages: 1591 - 1591
Prognostic effect of a vasopressin V2 receptor antagonist in acute congestive heart failure patients with hypoperfusion, the wet–cold pattern Kenichi MatsushitaKazumasa HaradaMorimasa Takayama Research 21 August 2024
Serious gaming as potential training tool for recognition of adverse drug reactions: side-effect exposure—medical education (SeeMe) Ingmar BergsLaura BellKatja S. Just Research Open access 19 August 2024
Evaluation of SLC6A2 and CYP2D6 polymorphisms’ effects on atomoxetine treatment in attention deficit and hyperactivity disorder Ismail Hasan KolePınar VuralCaner Mutlu Research 19 August 2024
Model-informed dose optimization of mycophenolic acid in pediatric kidney transplant patients Astrid HeidaNynke G. L. JagerRob ter Heine Research Open access 17 August 2024
Therapeutic drug monitoring for valproate: deriving a novel formula for calculation of free concentration Erna PretoriusPaulina van ZylGina Joubert Research Open access 16 August 2024
Short-term usage of proton pump inhibitors during admission was associated with increased risk of rehospitalization in critically ill patients with myocardial infarction: a cohort study Jia-De ZhuLi-Juan YangGong-Hao He Research 14 August 2024
Characteristics of isoniazid-induced psychosis: a systematic review of case reports and case series Keerthanaa BRashmi AppajiMahadev Rao Research Open access 13 August 2024
Reliability and validity of the Turkish version of the medication practical barriers to adherence questionnaire in patients with chronic diseases Nora SamuelyanPınar AyBetul Okuyan Research 07 August 2024
Efficacy and safety of ramucirumab for gastric or gastro-esophageal junction adenocarcinoma: a systematic review and meta-analysis Ruiqi RenZhewei ZhangJingzhou Wang Research 05 August 2024
Drug administration via feeding tubes—a procedure that carries risks: systematic identification of critical factors based on commonly administered drugs in a cohort of stroke patients Jana SommerfeldtHannes SartoriusChristoph A. Ritter Review Open access 29 July 2024
Neuronal toxicity of monoclonal antibodies (mAbs): an analysis of post-marketing reports from FDA Adverse Event Reporting System (FAERS) safety database Nitin KumarVivekanandan KalaiselvanMandeep Kumar Arora Research 25 July 2024
Correction to: Immune‑related serious adverse events with immune checkpoint inhibitors: systematic review and network meta‑analysis Clara OliveiraBeatrice MainoliJoão Costa Correction Open access 24 July 2024 Pages: 1597 - 1598
Author’s reply to the letter to the editor: “Effects of dapagliflozin and empagliflozin on 6‑min walk distance in heart failure with preserved and reduced ejection fraction: A systematic review and meta‑analysis of randomized controlled trials involving 2624 patients” Mohammad TanashatAlmothana ManasrahMohamed Abouzid Correspondence 23 July 2024
Letter to the editor: "Effects of dapagliflozin and empagliflozin on 6-min walk distance in heart failure with preserved and reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials involving 2624 patients" Kazumasa KotakeKazuki AdachiYuki Nakano Correspondence 21 July 2024
No evidence of clinical efficacy of oxomemazine in cough, according to a systematic review Trystan BaconClara BlanchardRémy Boussageon Research 17 July 2024 Pages: 1593 - 1595
Use of antibiotics in the early COVID-19 pandemic in Poland, the Netherlands and Spain, from erraticism to (more) logic Aleksandra OpalskaHelga GardarsdottirHubert Leufkens Research Open access 17 July 2024 Pages: 1581 - 1589
Statin treatment for primary and secondary prevention in elderly patients—a cross-sectional study in Stockholm, Sweden Björn WettermarkCamelia KalantaripourPaul Hjemdahl Research Open access 16 July 2024 Pages: 1571 - 1580
Effects of active vitamin D analogs and calcimimetic agents on PTH and bone mineral biomarkers in hemodialysis patients with SHPT: a network meta-analysis Xing LiuYichen LiuLimei Zhou Research 13 July 2024 Pages: 1555 - 1569
Consumers’ knowledge and experiences of adverse drug reaction reporting in Australia: a national survey Mohammed Gebre DedefoRenly LimLisa Kalisch Ellett Research Open access 12 July 2024 Pages: 1543 - 1554
Efficacy of cannabis-based medicine in the treatment of Tourette syndrome: a systematic review and meta-analysis Ibrahim SeragMona Mahmoud ElsakkaMohamed Abouzid Review Open access 10 July 2024 Pages: 1483 - 1493
Efficacy and safety of different pharmacological interventions in the treatment of tardive dyskinesia: a systematic review and network meta-analysis Omar IsmailKaram AlbdourAmeen Alsaras Review 06 July 2024 Pages: 1471 - 1482
Time-course and dose-effect of omalizumab in treating chronic idiopathic urticaria/chronic spontaneous urticaria Aiping ZhaoKe ZhangGuanghu Zhu Review 05 July 2024 Pages: 1461 - 1469
Impact of CYP2D6*2, CYP2D6*35, rs5758550, and related haplotypes on risperidone clearance in vivo Elisabet StørsetLine Skute BråtenMarianne Kristiansen Kringen Research Open access 04 July 2024 Pages: 1531 - 1541
Real-world safety and effectiveness of pirfenidone and nintedanib in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis Mengjia KouYang JiaoWan Wei Review 04 July 2024 Pages: 1445 - 1460
Effect of subcutaneous vs. intravenous tocilizumab in patients with severe COVID-19: a systematic review Yun LiXianlin LiXiaojun Zheng Research 27 June 2024 Pages: 1523 - 1530
Risk of renal impairment in atypical antipsychotics: a systematic review and meta-analysis Leong Tung OngNicholas Ming Zher CheeAudrey Joe Chii Loh Review 25 June 2024 Pages: 1435 - 1444
Use of drugs for hypertension or heart failure and the risk of death in COVID-19: association with loop-diuretics Johan FastbomGudrun Jonasdottir BergmanAnastasia Nyman Iliadou Research Open access 24 June 2024 Pages: 1515 - 1522
Risk of agranulocytosis with metamizole in comparison with alternative medications based on health records in Spain Miguel-Ángel Maciá-MartínezBelén Castillo-CanoElisa Martín-Merino Research 22 June 2024 Pages: 1503 - 1514
Is atezolizumab plus bevacizumab as first-line therapy for unresectable hepatocellular carcinoma superior to lenvatinib? a systematic review and meta‑analysis Gang ZhuLongfei ZengTao Wu Review 22 June 2024 Pages: 1425 - 1434
Development and validation of individualized tacrolimus dosing software for Chinese pediatric liver transplantation patients: a population pharmacokinetic approach Siyu YangJian WeiXingang Li Research 21 June 2024 Pages: 1409 - 1420
